NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report
Abstract Background NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efficacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants ar...
Збережено в:
| Автори: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SpringerOpen
2021-11-01
|
| Серія: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s41983-021-00397-y |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|